id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-1021-0102,FDA,FDA-2012-N-1021,Instructions for Submitting Comments on the CDRH Fiscal Year 2026 Proposed Guidance Development,Other,Correspondence,2025-10-01T04:00:00Z,2025,10,2025-10-01T04:00:00Z,2025-12-02T04:59:59Z,2025-12-02T10:00:22Z,,0,0,09000064b8feb6af